Erik E Rabin, Jonathan Huang, Miri Kim, Andreas Mozny, Kristen L Lauing, Manon Penco-Campillo, Lijie Zhai, Prashant Bommi, Xinlei Mi, Erica A Power, Vikram C Prabhu, Douglas E Anderson, Kevin P Barton, Theresa L Walunas, Gary E Schiltz, Christina Amidei, Pilar Sanchez-Gomez, Jigisha P Thakkar, Rimas V Lukas, Derek A Wainwright
BACKGROUND: Increased age is a strong and unfavorable prognostic factor for patients with glioblastoma (GBM). However, the relationships between stratified patient age, comorbidities, and medications have yet to be explored in GBM patient survival analyses. OBJECTIVE: To evaluate co-morbid conditions, tumor-related symptoms, medication prescriptions, and subject age for patients with GBM and to establish potential targets for prospective studies. METHODS: Electronic health records for 565 patients with IDHwt GBM were evaluated at a single center between January 1, 2000 and August 9, 2021 were retrospectively assessed...
July 2024: Brain, behavior, & immunity health